At Beeken Biomedical®, we are committed to saving lives through innovative hemostasis products. Uncontrolled blood loss in the hospital setting can lead to death, blood transfusions, infection and increase operative time and cost1. Hemorrhage is the leading cause of civilian and combat related deaths2,3
Beeken Biomedical® is passionate about finding solutions to improve patient outcomes for blood loss. We have developed a variety of hemostatic wound dressings to rapidly stop bleeding. Our NuStat® product portfolio, featuring Hemafiber Technology®, requires no preparation, is durable, absorbent and easy to apply.
NuStat Trauma Pad® XR and NuStat Flex® XR are designed to address the challenges of bleeding in the hospital setting. Both products offer X-Ray detectable threads and have recently been approved for severe internal organ surgical bleeds. This new approval allows NuStat TraumaPad® XR and NuStat Flex® XR to be used in all parts of a hospital, including all surgical procedures.
NuStat Tactical® and NuStat® OTC are designed to address the challenges of bleeding in the Public Safety Market. More than ever, we understand that having the right tools is essential for responders on the frontlines. Our technology enables first responders to rapidly control life-threatening bleeding so that the patient can be transported for further medical and surgical intervention.
On behalf of the Beeken Biomedical® team, we appreciate the opportunity to work with you to stop and stabilize life-threatening bleeding both inside and outside of the hospital.
Sincerely,
Richard Kendall
President and CEO
Beeken Biomedical
1. Marrietta M, et al. Transplant Proc. 2006 Apr;38(3):812-4.
2. Curry N et al. Crit Care. 2011;15(2):R92.
3. https://www.theguardian.com/technology/2006/nov/30/insideit.guardianweeklytechnologysection